The Scientist

» open access and disease/medicine

Most Recent

image: New Down Syndrome Protein Found

New Down Syndrome Protein Found

By | March 26, 2013

Researchers identify a protein involved in the chromosomal disorder that could explain its characteristic learning deficits.

0 Comments

image: Week in Review, March 18-22

Week in Review, March 18-22

By | March 22, 2013

Venom-based drugs for pain; microbes in the deep ocean; altruistic, suicidal bacteria; a call for open access; clinical sequencing; the newest genomes

0 Comments

image: Opinion: Open-Access for the 3rd World

Opinion: Open-Access for the 3rd World

By | March 21, 2013

Scientists should submit their work to open-access repositories to support research in parts of the world that don’t have access to the vast libraries of pay-wall-constrained literature.

3 Comments

image: Anthrax Vax Test OK for Kids

Anthrax Vax Test OK for Kids

By | March 19, 2013

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

9 Comments

Popular Now

  1. Trump’s Proposed Budget Would Cut Science Funding
  2. Unstructured Proteins Help Tardigrades Survive Desiccation
  3. Science Advocates Decry Trump’s Proposed Budget
  4. Human Gut Microbe Transplant Alters Mouse Behavior
Business Birmingham